KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microvision (MVIS) Other Accumulated Expenses (2020 - 2025)

Microvision's Other Accumulated Expenses history spans 6 years, with the latest figure at $388000.0 for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses fell 15.28% year-over-year to $388000.0; the TTM value through Dec 2025 reached $388000.0, down 15.28%, while the annual FY2025 figure was $388000.0, 15.28% down from the prior year.
  • Other Accumulated Expenses for Q4 2025 was $388000.0 at Microvision, down from $672000.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.9 million in Q3 2021 and bottomed at $24000.0 in Q2 2024.
  • The 5-year median for Other Accumulated Expenses is $466000.0 (2022), against an average of $630857.1.
  • The largest annual shift saw Other Accumulated Expenses skyrocketed 170.85% in 2023 before it plummeted 57.04% in 2025.
  • A 5-year view of Other Accumulated Expenses shows it stood at $1.9 million in 2021, then plummeted by 86.89% to $247000.0 in 2022, then surged by 170.85% to $669000.0 in 2023, then tumbled by 31.54% to $458000.0 in 2024, then decreased by 15.28% to $388000.0 in 2025.
  • Per Business Quant, the three most recent readings for MVIS's Other Accumulated Expenses are $388000.0 (Q4 2025), $672000.0 (Q3 2025), and $116000.0 (Q1 2025).